Cleared Traditional

K102681 - ADVIA CENTAUR TOXOPLASMA IGG (TOXO G) (FDA 510(k) Clearance)

May 2011
Decision
229d
Days
Class 2
Risk

K102681 is an FDA 510(k) clearance for the ADVIA CENTAUR TOXOPLASMA IGG (TOXO G). This device is classified as a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II - Special Controls, product code LGD).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on May 4, 2011, 229 days after receiving the submission on September 17, 2010.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3780.

Submission Details

510(k) Number K102681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2010
Decision Date May 04, 2011
Days to Decision 229 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3780